Chemoinformaics analysis of Desmethoxy encecalin
| Molecular Weight | 232.279 | nRot | 2 |
| Heavy Atom Molecular Weight | 216.151 | nRig | 12 |
| Exact Molecular Weight | 232.11 | nRing | 2 |
| Solubility: LogS | -3.911 | nHRing | 1 |
| Solubility: LogP | 3.254 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 36.4547 |
| nHD | 0 | BPOL | 20.3913 |
| QED | 0.735 |
| Synth | 2.607 |
| Natural Product Likeliness | 1.789 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.979 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.63 |
| MDCK | 0.0000218 |
| BBB | 0.558 |
| PPB | 0.905072 |
| VDSS | 1.077 |
| FU | 0.0852123 |
| CYP1A2-inh | 0.965 |
| CYP1A2-sub | 0.89 |
| CYP2c19-inh | 0.817 |
| CYP2c19-sub | 0.789 |
| CYP2c9-inh | 0.507 |
| CYP2c9-sub | 0.875 |
| CYP2d6-inh | 0.801 |
| CYP2d6-sub | 0.733 |
| CYP3a4-inh | 0.204 |
| CYP3a4-sub | 0.566 |
| CL | 6.02 |
| T12 | 0.407 |
| hERG | 0.029 |
| Ames | 0.025 |
| ROA | 0.075 |
| SkinSen | 0.211 |
| Carcinogencity | 0.887 |
| EI | 0.378 |
| Respiratory | 0.892 |
| NR-Aromatase | 0.113 |
| Antiviral | Yes |
| Prediction | 0.627369 |